Cordella system measures, records, and transfers pulmonary artery pressure data from a heart failure patient’s home to clinicians. Credit: Robina Weermeijer on Unsplash.

Digital health and medical technology company Endotronix has concluded the enrolment of patients for a trial to evaluate the safety and efficacy of the Cordellapulmonary artery (PA) sensor system.

Dubbed the PROACTIVE-HF, the pivotal trial is claimed to be the first global investigational device exemption (IDE) study for PA pressure-guided heart failure (HF) management.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The company recruited more than 450 patients across the US, Ireland and Belgium for the PROACTIVE-HF, which is an open-label, single-arm, multi-centre clinical trial.

Mortality, HF hospitalisations, and device safety are the primary endpoints of the study.

Primary endpoint data from the study is expected to be reported in the first half of next year.

Endotronix will use the data from the trial to support its pre-market approval (PMA) application for the device in the US.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Endotronix CEO and co-founder Harry Rowland said: “I would like to congratulate all our clinical partners on their tremendous effort to complete enrollment for PROACTIVE-HF.

“Their hard work and dedication are key to improving outcomes and expanding patient access, and we appreciate their continued commitment to this trial.”

The Cordella system is designed to measure, record and transfer data related to pulmonary artery pressure (PAP) from the patient’s home to clinicians for evaluation and proactive, patient-centred remote HF management.

Comprising seven subsystems, the system takes daily PAP readings at a patient’s home and transfers the data to a care provider for assessment.

The subsystems include Cordella Sensor, Cordella Delivery System, myCordella Patient Reader, Reader Dock, Cordella Calibration Equipment (CalEQ), myCordella hub and Cordella Data Analysis Platform (CDAP).

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now